Αποτελέσματα Αναζήτησης
27 Μαΐ 2011 · The most commonly observed side effects after the introduction of the augmenting agent included akathysia (25%), nausea/vomiting (15%), hyperkinesia (15%), Tension/Inner unrest (10%), tremors and asthenia/lassitude/increased fatiguability (10%).
- Aripiprazole-induced obsessive–compulsive symptoms - PMC
There is recent evidence for a beneficial effect of...
- Augmentation strategies in obsessive-compulsive disorder
Around 40-60% of patients with obsessive-compulsive disorder...
- Aripiprazole-induced obsessive–compulsive symptoms - PMC
9 Ιαν 2014 · To summarize, risperidone appears to be the drug of choice when an antipsychotic is considered for augmentation in OCD, followed by aripiprazole and haloperidol, while olanzapine and quetiapine need to be studied further.
29 Αυγ 2012 · Antipsychotic augmentation is a common strategy for treatment resistant OCD. This trial evaluated the efficacy of adding aripiprazole in patients whose OCD was insufficiently responsive to an adequate SSRI treatment.
23 Αυγ 2022 · Some serious side effects of Abilify include: uncontrollable or involuntary movements (such as tremors) metabolism changes (such as high blood sugar or high cholesterol)
21 Δεκ 2021 · There is recent evidence for a beneficial effect of aripiprazole in obsessive–compulsive disorder (OCD). However, more recently, a few case reports indicated worsening and emergence of OCS during treatment with aripiprazole.
Around 40-60% of patients with obsessive-compulsive disorder do not show adequate response to selective serotonin reuptake inhibitors (SSRIs). Augmentation strategies are recommended in people who show partial response to SSRI treatment or poor response to multiple SSRIs. In this article, the authors review the evidence for augmentation strategies.
29 Ιουλ 2024 · Explore how Abilify aids in OCD treatment, its benefits, potential side effects, and best practices for effective management.
